Northwest & Ethical Investments L.P. Grows Position in Genpact Limited (NYSE:G)

Northwest & Ethical Investments L.P. lifted its position in shares of Genpact Limited (NYSE:GFree Report) by 10.7% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 290,166 shares of the business services provider’s stock after buying an additional 28,068 shares during the period. Northwest & Ethical Investments L.P.’s holdings in Genpact were worth $11,377,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in G. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in shares of Genpact during the third quarter worth about $4,365,000. Glenmede Trust Co. NA lifted its position in Genpact by 2.2% during the 3rd quarter. Glenmede Trust Co. NA now owns 43,156 shares of the business services provider’s stock worth $1,692,000 after acquiring an additional 926 shares in the last quarter. BNP Paribas Financial Markets boosted its holdings in Genpact by 78.8% in the 3rd quarter. BNP Paribas Financial Markets now owns 47,957 shares of the business services provider’s stock worth $1,880,000 after acquiring an additional 21,140 shares during the period. Centaurus Financial Inc. acquired a new stake in Genpact in the third quarter valued at approximately $159,000. Finally, Cerity Partners LLC raised its stake in shares of Genpact by 136.4% during the third quarter. Cerity Partners LLC now owns 17,935 shares of the business services provider’s stock valued at $703,000 after purchasing an additional 10,349 shares during the period. 96.03% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on G. Robert W. Baird upped their target price on shares of Genpact from $44.00 to $48.00 and gave the company a “neutral” rating in a research note on Friday, November 8th. BMO Capital Markets upped their price objective on shares of Genpact from $38.00 to $42.00 and gave the company a “market perform” rating in a research report on Monday, August 12th. Jefferies Financial Group lifted their target price on Genpact from $35.00 to $40.00 and gave the stock a “hold” rating in a research report on Monday, September 9th. TD Cowen increased their price target on Genpact from $40.00 to $45.00 and gave the company a “hold” rating in a report on Friday, November 8th. Finally, JPMorgan Chase & Co. upped their target price on Genpact from $35.00 to $43.00 and gave the company a “neutral” rating in a research report on Friday, September 6th. Eight analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $42.33.

Read Our Latest Report on Genpact

Insider Buying and Selling

In related news, CEO Balkrishan Kalra sold 9,000 shares of the business’s stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $46.40, for a total transaction of $417,600.00. Following the completion of the sale, the chief executive officer now owns 267,404 shares of the company’s stock, valued at $12,407,545.60. This represents a 3.26 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 2.80% of the stock is currently owned by company insiders.

Genpact Trading Down 0.7 %

Shares of NYSE G opened at $46.49 on Friday. The company has a quick ratio of 1.85, a current ratio of 1.85 and a debt-to-equity ratio of 0.50. The stock’s 50 day moving average price is $41.02 and its two-hundred day moving average price is $36.89. Genpact Limited has a 52-week low of $30.23 and a 52-week high of $47.98. The stock has a market capitalization of $8.20 billion, a P/E ratio of 12.77, a PEG ratio of 1.60 and a beta of 1.13.

Genpact Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, December 23rd. Investors of record on Monday, December 9th will be given a dividend of $0.1525 per share. This represents a $0.61 annualized dividend and a dividend yield of 1.31%. The ex-dividend date of this dividend is Monday, December 9th. Genpact’s dividend payout ratio is currently 16.76%.

About Genpact

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

See Also

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:GFree Report).

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.